EVIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events

On July 12, 2021, EVIO, Inc. announced that it entered into a Letter of Intent to acquire Leading Edge Pharms, Inc. ("LEP") of Henderson, Nevada, pending shareholder approval. LEP is a biotechnology company focused on the research, development and commercialization of novel cannabinoid therapies and innovative drug delivery systems.

Terms of the acquisition include EVIO to perform detailed due diligence including technical review and testing of the company's products and methods. Closing of the transaction will be subject to; shareholder approval, authorization of additional shares to support the acquisition, EVIO will add at least two board members from LEP, and EVIO will release its audited financials. Upon completion of the deal, LEP will fill certain executive roles of the company.

Item 9.01 Financial Statements and Exhibits

  Exhibit     Press Release - EVIO, Inc. Enters into Letter of Intent to Acquire
10.1        Leading Edge Pharms, Inc.





2

© Edgar Online, source Glimpses